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Gregory J. Dehmer, MD
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Efforts to publicly report healthcare outcomes are not new.
In what may be the earliest effort at public reporting,
Florence Nightingale published the mortality rates at
English hospitals (1). Her report was not well received nor
was the initiative of Dr. Ernest Codman, an advocate of
hospital reform, when he called for the public release of
surgical outcomes some 50 years later (2). Public reporting
efforts remained dormant until the 1980s when risk-
adjusted death rates at U.S. hospitals became public (3).
These too were widely criticized and, irrespective of their
results, administrators from a broad range of hospitals
expressed concerns about the accuracy, appropriateness, and
helpfulness of these data (4). The pace of public reporting
efforts is accelerating with numerous government agencies
and independent organizations releasing increasing amounts
of information. Public reporting will continue as contained
within the Affordable Care Act of 2010. The secretary of
Health and Human Services was directed to establish a
national strategy for quality improvement that includes
public reporting of performance information on quality,
cost, and other metrics through healthcare quality websites
by 2014.
See page 625
The foundation upon which public reporting exists is the
belief that the information provided will affect decisions and
behaviors of the various stakeholders and will ultimately
result in an improvement in healthcare delivery. This
assumption, however, has not been convincingly proven (5).
Skeptics of public reporting voice many concerns about
the accuracy and reliability of the information in reports
and weaknesses in the risk-adjustment methods that are*Editorials published in JACC: Cardiovascular Interventions reﬂect the views of the
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system could be “gamed” by providers and consumers could
misinterpret data if they do not understand the terminology
or context of a public report. Several papers have suggested
that the public release of data resulted in unintended
negative consequences for patient care (6–11). The paper
by McCabe et al. (12) in this issue of JACC: Cardiovascular
Interventions adds to this concern.
Massachusetts has publicly reported risk-adjusted mor-
tality for percutaneous coronary intervention (PCI) since
2003. Over this period, 4 of the 24 hospitals performing
PCI in the state were identiﬁed in a public report as
outliers because of a risk-adjusted mortality higher than
the state average. McCabe et al. try to determine if iden-
tiﬁcation of a hospital as an outlier caused operators at the
facility to decline high-risk cases. They examined the
hospital’s change in predicted in-hospital mortality over
time with the hypothesis that facilities identiﬁed as outliers
would have a decrease in predicted mortality, indicating
a shift away from doing high-risk cases. Following public
identiﬁcation as an outlier, they found an 18% relative
reduction in predicted mortality among PCI patients at
outlier institutions, suggesting that, on average, PCI
patients at outlier hospitals were less severely ill. Further-
more, they found an additional 37% relative reduction in
predicted mortality risk among all PCI patients in
Massachusetts. Because risk-adjusted mortality for coro-
nary artery bypass graft surgery is reported in Massachu-
setts, the investigators examined the expected mortality for
surgical patients at outlier hospitals, thinking it might
increase if more high-risk patients were referred for coro-
nary artery bypass graft. In fact, it did the opposite, sug-
gesting high-risk PCI patients were not referred for
surgery. It would be ideal to know the outcome of indi-
vidual high-risk patients to understand if, in fact, patients
needing PCI were denied the procedure and died or
perhaps were treated medically and survived. However, this
comment is not meant to cast doubt on the investigators’
conclusion that being labeled an outlier caused operators to
be more adverse to risk. Although McCabe et al. used
several prediction models and assumptions that could
introduce errors, I believe their results. Who remembers
falling off your bicycle and skinning a knee as a child and
then going a bit slower on your next bicycle ride? How
many drivers instinctively slow down when they pass
a police ofﬁcer issuing a ticket to another motorist? If your
hospital were zapped as an outlier in a public report, would
you want to try for 2 in a row?
There is no question that the topic of public reporting of
healthcare outcomes is in the spotlight. For years, formal
data about the performance of hospitals and physicians was
simply unavailable. Information about good or bad hospitals
or physicians was shared by word of mouth in a community
if at all. Times have changed regarding our access to
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632information. Thanks to the Internet, search engines, and
multiple social media sites, you can ﬁnd incredible amounts
of information and misinformation online about any topic.
We have now become well-informed consumers who care-
fully research the quality and price of a refrigerator before
ever entering a store. Should we not be doing that for health
care? Decisions about your health are some of the most
important decisions you will make, so many now advocate
that information about physicians and healthcare facilities be
available for all to see. Nobody would hire a plumber rated
as the worst in the area to ﬁx a clogged pipe, so why would
you want your clogged coronary ﬁxed by a “negative outlier”?
It all sounds so clean and simple, but that is not the case.
Public reporting is very complex and makes many in health
care nervous. Their secret wish is for it to disappear like
a bad dream, but public reporting is here to stay. The
challenges ahead are how best to develop public reporting for
a good purpose and yet avoid unintended consequences such
as the risk-adverse behavior.
Nobody disputes mortality as an important outcome, but
making judgments about the overall quality of a program
based on a very uncommon event like mortality has weak-
nesses. Hospitals in Massachusetts were identiﬁed as
outliers because their risk-adjusted mortality was signiﬁ-
cantly above the statewide average in a given year. The
potential pitfalls of this are illustrated with the following
statistical model, which is especially relevant considering
recent data from the National Cardiovascular Data Registry
showing that 49% of facilities perform <400 PCIs annually
and 26% perform <200 PCIs annually (13). Assume the
average state PCI mortality is 1%, but in a given year, an
individual hospital has a mortality of 2%. At a facility
volume of 400 cases annually and using a 95% conﬁdence
interval, it would take just about 2 years of data at 2%
mortality to be certain the increase was signiﬁcant rather
than variation; at a facility volume of 200 PCIs annually, it
would take almost 4 years to be certain. Therefore, as PCI
volumes decrease, using a hospital’s risk-adjusted mortality
as the sole measure of quality is problematic.
Mortality cannot be ignored, but when thrust into
a situation where a high-risk PCI is the best (and some-
times only) option for a patient, the outcome may not be
good despite the best efforts of the operator and the entire
catheterization team. Primum non nocere or “ﬁrst do no
harm” is a phrase we heard early in medical training, but
we should not be paralyzed daily by fear that 1 bad
outcome from a potentially lifesaving and appropriate
procedure will harm a physician’s or hospital’s reputation.
How is the line drawn between a procedure that is truly
futile, and another that has a chance, albeit small, of
saving a life? Data from a spreadsheet and statistical
number crunching may be ﬁne if you are trying to show
that patients are receiving the correct medications before
and after a PCI, but they may not be ideal for a complexoutcome such as mortality. The challenge moving forward
is how do we satisfy the increasing demands for public
reporting and not have this process lead to inappropriate
conclusions by the public or unintended consequences?
Most major research trials have independent data safety
and monitoring boards and a process whereby clinical
events, such as mortality, are carefully reviewed with
a determination whether the event was really related to the
therapy being studied. In a similar fashion, unbiased
peer review may be necessary to fully understand the cir-
cumstances surrounding a PCI-related mortality, and this
goes well beyond the process of risk adjustment. Obtain-
ing such peer review is difﬁcult, especially at smaller
hospitals, but there are independent professional organi-
zations that provide this service. Perhaps in the future the
ideal model would be to report both risk-adjusted and
adjudicated mortality rates with an explanation of how
these are different.
Several organizations, including the American College
of Cardiology and Society for Cardiovascular Angiography
and Interventions, have developed principles and guide-
lines for public reporting, but it is not clear whether these
are being followed by the many entities that now make the
healthcare information public (14,15). Just as it is easy to
be bombarded by information from the Internet, being
bombarded by public reports of healthcare outcomes from
multiple sources that often provide conﬂicting information
is not helpful. As an acquaintance recently quipped, “It’s
amazing that in America there appear to be over 300
hospitals in the top 100”. All physicians need to under-
stand that you can run, but in the near future, there will be
nowhere to hide from public reporting. How will we adapt
to this new era of transparency? Consider the following
steps. First, clinical practice guidelines are not perfect, but
following guideline-directed therapy is unlikely to get one
labeled as an outlier. Second, know the performance
measures that apply to your area of practice. These describe
measurable aspects of care that are ripe for public report-
ing. Third, know your numbers. Several years ago, the
American Heart Association launched a campaign to
encourage patients to know their lipid, glucose, blood
pressure, and weight numbers. Hospitals and physicians
should now know their numbersdthat is, how they
perform on key metrics against national benchmarks. Data
are available, but, surprisingly, they are not reviewed on a
regular basis or used optimally for quality improvement.
Know your data and be proactive in efforts to improve.
Understand that in the near future, there will be new
payment models that are based not on the quantity of care,
but on the quality of care you provide. Finally, be patient-
centered, putting the best interests of the patient ﬁrst in
daily decisions. We are entering into an era of transparency
that will require time and careful thought before the right
balance between too little and too much information is
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633achieved. The example provided by McCabe et al. shows
there is still work to be done.
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